Asim Afaq, M.D.

Associate Professor

School: Medical School
Department: Radiology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Biography

Asim Afaq, M.D., is an Associate Professor of Radiology at UT Southwestern Medical Center and a member of its Abdominal Imaging Division.

Dr. Afaq joined our faculty in August 2023.

Education

Other Post Graduate Training: University College of London 2019
Medical School: Imperial College London, University of London, School of Medicine (2002)
Internship: University of London (2005), Internal Medicine & General Surgery
Residency: Imperial College Healthcare, NHS Trust (2010), Radiology
Fellowship: Royal Marsden Hospital (2010), Radiology
Fellowship: Memorial Sloan Kettering Cancer Center (2012), Molecular Imaging

Publications

Clinical Implementation of PSMA-PET Guided Tumor Response-Based Boost Adaptation in Online Adaptive Radiotherapy for High-Risk Prostate Cancer: Li R, Lin M, Nguyen NC, Su FC, Parsons DD, Salcedo E, Phillips E, Domal S, Garant A, Hannan R, Yang DX, Afaq A, Lee M, Oz OK, Desai NB Cancers 2025 Sep 17
Current Applications of PET/MR: Part II: Clinical Applications II: Kohan A, Hanneman K, Mirshahvalad SA, Afaq A, Mallak N, Metser U, Veit-Haibach P Canadian Association of Radiologists Journal 2024 Nov 75 826-837
Deep learning applications for quantitative and qualitative PET in PET/MR: technical and clinical unmet needs: Yang J, Afaq A, Sibley R, McMilan A, Pirasteh A Magnetic Resonance Materials in Physics, Biology and Medicine 2024 Aug 37 749-763
⁶⁸Ga-PSMA-Avid Intranasal Solitary Fibrous Tumor: Riaz S, Priftakis D, Afaq A, Kayani I, Bomanji J Clinical nuclear medicine 2023 Apr 48 E184-E185
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer: Wang Y, Galante JR, Haroon A, Wan S, Afaq A, Payne H, Bomanji J, Adeleke S, Kasivisvanathan V Nature Reviews Urology 2022 Aug 19 475-493
Impact of ¹⁸F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy: Author Collaboration F, Payne H, Bomanji J, Bottomley D, Scarsbrook AF, Teoh EJ, Gleeson FV, Bradley KM, Andrade G, Camilieri P, Hyde K, Macpherson R, Patel N, Sabharwal A, Subesinghe M, Chau A, Miller MP, Afaq A, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Han S, Leung HY Nuclear Medicine Communications 2022 Feb 43 201-211
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 49, 1, (371-384), 10.1007/s00259-021-05318-y): Chen SH, Miles K, Taylor SA, Ganeshan B, Rodriquez M, Fraioli F, Wan S, Afaq A, Shortman R, Walls D, Hoy L, Endozo R, Bhargava A, Hanson M, Huang J, Raouf S, Francis D, Siddiqi S, Arulampalam T, Sizer B, Machesney M, Reay-Jones N, Dindyal S, Ng T, Groves AM European Journal of Nuclear Medicine and Molecular Imaging 2022 Jan 49 786-787
A Phase II, Open-Label Study to Assess Safety and Management Change Using ⁶⁸Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study: Afaq A, Payne H, Davda R, Hines J, Cook GJ, Meagher M, Priftakis D, Warbey VS, Kelkar A, Orczyk C, Mitra A, Needleman S, Ferris M, Mullen G, Bomanji J Journal of Nuclear Medicine 2021 Dec 62 1727-1734
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis: Chen Sh, Miles K, Taylor SA, Ganeshan B, Rodriquez M, Fraioli F, Wan S, Afaq A, Shortman R, Walls D, Hoy L, Endozo R, Bhargava A, Hanson M, Huang J, Raouf S, Francis D, Siddiqi S, Arulampalam T, Sizer B, Machesney M, Reay-Jones N, Dindyal S, Ng T, Groves AM European Journal of Nuclear Medicine and Molecular Imaging 2021 Dec 49 371-384
Pitfalls on PET/MRI: Afaq A, Faul D, Chebrolu VV, Wan S, Hope TA, Haibach PV, Bomanji J Seminars in Nuclear Medicine 2021 Sep 51 529-539